Contract Services Market Place Enquiry

Looking for a CMO to develop homeopathic sterile eye drops in the United States [ENA05116]

A pharmaceutical company manufacturing its own proprietary formulas is looking for a CMO to develop homeopathic sterile eye drops (15 ml) containing Sodium Chloride and Potassium Chloride. The required quantity for the initial order is 25,000 units.

10 Sep 2019

Chat View (1)

Reply

Looking for a EUGMP approved CMO to perform Laser diffraction technique in Croatia [ENA05068]

A pharmaceutical manufacturing company developing new products that meet the needs of the demanding foreign market is looking for a EUGMP approved CMO to perform analysis of droplet size distribution by the laser diffraction technique for release testing and for stability testing.

04 Sep 2019

Chat View (1)

Reply

Looking for a CMO to develop Clomipramine HCl tablets in the Austria [ENA05060]

A leading pharmaceutical manufacturing company in Austria is looking for a CMO to develop Clomipramine HCl tablets. The required dosage strength along with volume forecast is mentioned below:
1. Clomipramine HCl (10 mg) tablets - 233,500 units
2. Clomipramine HCl (25 mg) tablets - 813,500 units
3. Clomipramine HCl (75 mg) tablets - 632,500 units.

03 Sep 2019

Chat View (3)

Reply

Looking for an EU based CMO for ophthalmic medical devices in Azerbaijan [ENA04966]

The largest and fastest growing pharmaceuticals distributor in Azerbaijan is looking for an EU based CMO for manufacturing medical devices of ophthalmic products (in drop or monodose, spray form). The multicombination formulations that will be used in ophthalmic medical devices are:
1. Citicoline+B12 drops
2. Liposomes+green tea extract drops
3. HMW Sodium Hyaluronate 0.02% and LMW Sodium Hyaluronate 0.02% also containing L-Glycine, Vit. E-TPGS, Centella Asiatica, Dry Hydroalcoholic Extract, PVP, D-Mannitol
4. Sodium Hyaluronate 0.2% containing Hypromellose 0.2%, Bilberry, Dog Rose, Aloe Vera, Chamomile distilled waters.

24 Aug 2019

Chat View (2)

Reply

Looking for a CDMO to develop Imatinib Mesylate Tablets/Capsules (120 mg) in the United States [ENA04955]

A specialty patient-centric life sciences company with a focus on novel and innovative drug delivery technologies that improve the clinical outcome in rare and orphan disease treatment is looking for a CDMO to develop Imatinib Mesylate tablets/Capsules (120 mg) for Phase 3 Clinical Study in the United States for IND registration. The formulation needs to be tableted or encapsulated and packaged for clinical studies in the US and EU.

22 Aug 2019

Chat View (6)

Reply

Looking for service provider for publishing of USFDA annual report in E-CTD format [ENA04908]

A company offering a wide range of services in research and development of manufacturing processes in the Czech Republic is looking for a service provider who provides the support for publishing of the USFDA annual report in E-CTD format.

16 Aug 2019

Chat View (6)

Reply

Looking for a GMP approved CMO to manufacture reformulated Docetaxel product [ENA04871]

A specialty pharmaceutical firm, based in the United States, focused on the development of next-generation proprietary formulations of sterile injectable drugs is looking for a GMP approved CMO to manufacture reformulated Docetaxel products with GLP stability and animal PK studies. The process includes the following steps:
1) Dissolve the API in Ethanol, i.e., 1g in 10 to 15 ml of Ethanol
2) Mix with 20% sugar-lipid polymer at a ratio of 20:1 (20 parts of polymer solution and 1 part of the drug in ethanol), the final Ethanol content is less than 5% in the mixed solution).
3) Add 2X volume of 5% mannitol, mixed well, sterile filled with 0.2 µm PTFE membrane filter, then dispatch 20 mg Docetaxel equivalent to each vial (20ml) and place under - 40 °C freezer.
4) The frozen mixture undergoes lyophilization.
The release test will follow the USP methods.

10 Aug 2019

Chat View (8)

Reply

Looking for a GMP approved CMO to manufacture 1% Propofol solution for Injection [ENA04863]

A specialty pharmaceutical firm, based in the United States, focused on the development of next-generation proprietary formulations of sterile injectable drugs is looking for a GMP approved CMO to manufacture the Propofol sterile solution for GLP stability and animal PK studies. Details related to the project are as follows:
1. 1% propofol solution (20 ml) for injection
2. It is a simple mixing process i.e., 1% propofol mix with 2% of the Sugar-lipid-PEG (excipient) in 5% dextrose at room or cool temperature.
3. 1000 vials will be needed
No special equipment will be needed.

09 Aug 2019

Chat View (2)

Reply

Looking for a cGMP approved CMO to manufacture Phenazopyridine HCl [ENA04782]

An innovative international pharmaceutical organization introducing their niche innovative specialty products is looking for a cGMP approved CMO to manufacture Phenazopyridine HCl film coated tablets (100 mg and 200 mg). The required volume forecast is about more than 1,000,000 units. The manufacturers should comply with Health Canada and USFDA inspected facility.

31 Jul 2019

Chat View (5)

Reply

Looking for a EUGMP CMO to manufacture vegetarian soft gel capsules [ENA04762]

A company using modern scientific resources to develop medicines based on plants is looking for a EUGMP CMO to manufacture vegetarian soft gel capsules for food supplement and also about possibility to manufacture succinate gelatin (bovine or fish origin) for soft gel shell. Additional information for this enquiry is as follows:
1. Volume Forecast- 300,000 to 1,000,000 units depending upon dosage strength
2. Primary Packaging- Blisters and Bottles with 100 units
3. Documentation Required- QMS, HACCP or FSSC 22.000 or GMP.

30 Jul 2019

Chat View (1)

Reply

Find

Market Place